SYK completes the acquisition of NICO to strengthen its portfolio of solutions for tumor resection and the treatment of ICH. Stryker (NYSE: SYK), a global leader in medical technologies, announced ...
PBH currently has a forward P/E ratio of 16.72, while SYK has a forward P/E of 30.43. We also note that PBH has a PEG ratio of 2.09. This popular metric is similar to the widely-known P/E ratio, with ...